ETPrime

Jagsonpal Pharmaceuticals Share Price

  • 220.44-2.44 (-1.10%)
  • Volume: 40,911
  • Closed
  • Last Updated On: 16 Oct, 2025, 03:53 PM IST
STOCK SCORE
ETPrime Only
High: "NaN",Open: "NaN",Low: "NaN",
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Jagsonpal Pharmaceuticals Share Price
  • 220.44-2.44 (-1.10%)
  • Volume: 40,911
Advertisment

Key Metrics

PE Ratio
(x)		24.11
EPS - TTM
(₹)		9.14
MCap
(₹ Cr.)		1,466.51
Sectoral MCap Rank
76
PB Ratio
(x)		6.18
Div Yield
(%)		1.13
Face Value
(₹)		2.00
Beta

Beta

1 Month1.10
3 Months0.39
6 Months0.32
1 Year0.40
3 Years1.08

1.10
VWAP
(₹)		221.32
52W H/L
(₹)
328.04 / 175.18

Jagsonpal Pharm share price insights

View All

  • Company delivered ROE of 23.11% in year ending Mar 31, 2025 outperforming its 5 year avg. of 16.83%. (Source: Standalone Financials)

  • Company's annual revenue growth of 27.03% outperformed its 3 year CAGR of 6.4%. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 23.86% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Jagsonpal Pharmaceuticals Ltd. share price moved down by -1.10% from its previous close of Rs 222.87. Jagsonpal Pharmaceuticals Ltd. stock last traded price is 220.44

    Share PriceValue
    Today/Current/Last220.44
    Previous Day222.87223.45

InsightsJagsonpal Pharm

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Jagsonpal Pharm Share Price Returns

    1 Day-1.1%
    1 Week3.02%
    1 Month-11.2%
    3 Months-10.5%
    1 Year22.63%
    3 Years62.47%
    5 Years1220.0%

    ET Stock ScreenersTop Score Companies

    Check whether Jagsonpal Pharm belongs to analysts' top-rated companies list?

    View Stock Screeners

    Jagsonpal Pharm News & Analysis

    View all Jagsonpal Pharm Share News & Announcements

    Jagsonpal Pharm Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Jagsonpal Pharm Share Recommendations

    • Target₹47
    • OrganizationNirmal Bang Securities
    • BUY

    That's all for Jagsonpal Pharm recommendations. Check out other stock recos.

    Jagsonpal Pharm Financials

    • Insights

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 27.03% outperformed its 3 year CAGR of 6.4%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 23.86% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income78.4461.3376.3576.3562.88
      Total Income Growth (%)27.89-19.670.0021.4136.78
      Total Expenses63.7552.3637.4260.7555.56
      Total Expenses Growth (%)21.7539.93-38.409.3434.78
      EBIT14.698.9738.9315.607.33
      EBIT Growth (%)63.77-76.96149.56112.9454.11
      Profit after Tax (PAT)10.806.5831.9911.465.33
      PAT Growth (%)63.98-79.42179.17115.0350.15
      EBIT Margin (%)18.7214.6250.9920.4311.65
      Net Profit Margin (%)13.7610.7341.9015.018.47
      Basic EPS (₹)1.600.9812.094.291.94
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue276.91217.98242.45229.43192.34
      Total Revenue Growth (%)27.03-10.095.6719.2919.40
      Total Expenses226.73188.11204.18202.11170.47
      Total Expenses Growth (%)20.53-7.871.0218.5612.39
      Profit after Tax (PAT)55.3622.4626.7219.5917.06
      PAT Growth (%)146.45-15.9436.4214.82116.73
      Operating Profit Margin (%)19.0214.7016.3412.2012.21
      Net Profit Margin (%)20.6010.7611.288.669.07
      Basic EPS (₹)8.268.4910.207.486.51

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets278.26217.08194.95168.45164.20
      Total Assets Growth (%)28.1811.3515.732.5911.74
      Total Liabilities38.3129.6836.0637.6042.27
      Total Liabilities Growth (%)29.08-17.69-4.10-11.0517.68
      Total Equity239.95187.40158.89130.86121.93
      Total Equity Growth (%)28.0417.9421.427.329.82
      Current Ratio (x)6.2210.425.973.242.98
      Total Debt to Equity (x)0.000.000.000.000.06
      Contingent Liabilities15.4611.226.095.875.99

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 45.15 cr for investing activities which is an YoY increase of 83.91%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities55.3035.1746.665.6028.22
      Net Cash used in Investing Activities-45.15-24.55-57.67-26.21-2.26
      Net Cash flow from Financing Activities-11.70-8.91-0.46-12.30-6.83
      Net Cash Flow-1.551.71-11.47-32.9119.13
      Closing Cash & Cash Equivalent11.2212.7611.0526.0358.94
      Closing Cash & Cash Equivalent Growth (%)-12.1115.44-57.54-55.8454.81
      Total Debt/ CFO (x)0.000.000.000.000.24

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 23.11% in year ending Mar 31, 2025 outperforming its 5 year avg. of 16.83%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)23.1111.9816.8115.9214.95
      Return on Capital Employed (%)20.2615.5023.1020.5518.54
      Return on Assets (%)19.8910.3413.7011.6210.38
      Interest Coverage Ratio (x)61.8639.7496.57102.1821.14
      Asset Turnover Ratio (x)1.081.011.301.36114.45
      Price to Earnings (x)25.9133.0028.4942.0212.22
      Price to Book (x)5.993.954.786.681.83
      EV/EBITDA (x)22.0218.3016.1727.316.60
      EBITDA Margin (%)22.0515.4916.8412.8812.48

      No reported Financial Ratios are available.

    Financial InsightsJagsonpal Pharm

    • Income (P&L)
    • Cash Flow
    • Ratios

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 27.03% outperformed its 3 year CAGR of 6.4%. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 23.86% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 45.15 cr for investing activities which is an YoY increase of 83.91%. (Source: Standalone Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 23.11% in year ending Mar 31, 2025 outperforming its 5 year avg. of 16.83%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Jagsonpal Pharm Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Jagsonpal Pharm Peer Comparison

    Peers InsightsJagsonpal Pharm

      Do you find these insights useful?

      • hate it

      • meh

      • love it

      Jagsonpal Pharm Shareholding Pattern

      • Loading...
        Showing Jagsonpal Pharm Shareholding as on Jun 2025
        CategoryJun 2025Mar 2025Dec 2024Sep 2024
        Promoters67.6567.7867.8167.97
        Pledge0.000.000.000.00
        FII2.172.102.102.30
        DII0.050.000.000.11
        Mutual Funds0.000.000.000.11
        Others30.1230.1230.0929.62
      • Showing Shareholding as on Jun 2025
        CategoryNo. of SharesPercentage% Change QoQ
        Promoters4,50,04,78567.65 %-0.12
        Pledge00.00 %0.00
        FII14,49,7542.17 %0.06
        DII31,3140.05 %-0.06
        MF29,5680.11 %0.11
        Others2,00,40,62730.12 %0.00

      Jagsonpal Pharm MF Ownership

      MF Ownership as on 30 September 2025

      View all Mutual Fund Schemes
      Top Searches:
      Jagsonpal Pharm News Jagsonpal Pharm Quarterly Results Jagsonpal Pharm Dividend Jagsonpal Pharm Q1 ResultsJagsonpal Pharm Q2 ResultsJagsonpal Pharm Q3 ResultsJagsonpal Pharm Q4 Results

      Jagsonpal Pharm Corporate Actions

      • Meeting DateAnnounced onPurposeDetails
        Sep 24, 2025Sep 01, 2025AGM-
        Jul 26, 2025Jul 23, 2025Board MeetingQuarterly Results
        May 06, 2025Apr 29, 2025Board MeetingAudited Results & Final Dividend
        Jan 22, 2025Jan 15, 2025Board MeetingQuarterly Results
        Dec 13, 2024Nov 11, 2024POM-
      • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
        Final125%2.5Sep 12, 2025May 06, 2025
        Final100%5.0Sep 06, 2024May 21, 2024
        Final100%5.0Aug 21, 2023May 23, 2023
        Interim80%4.0Oct 29, 2021Oct 19, 2021
        Final20%1.0Sep 22, 2021Jun 30, 2021
      • All TypesEx-DateRecord DateAnnounced onDetails
        SplitsJan 08, 2025Jan 08, 2025Oct 23, 2024Split: Old FV5.0| New FV:2.0
        SplitsJul 20, 2004Jul 28, 2004Apr 30, 2004Split: Old FV10.0| New FV:5.0
        BonusJul 20, 2004Jul 28, 2004Apr 30, 2004Bonus Ratio: 3 share(s) for every 1 shares held

      About Jagsonpal Pharm

      Jagsonpal Pharmaceuticals Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 1,466.51 Crore) operating in Pharmaceuticals sector. Jagsonpal Pharmaceuticals Ltd. key Products/Revenue Segments include Formulations, Active Pharma Ingredients for the year ending 31-Mar-2025. Show More

      • Executives

      • Auditors

      • RS

        Rajpal Singh Kochhar

        Chairman Emeritus
        HR

        Harsha Raghavan

        Chairman & Non-Exe.Director
        MG

        Manish Gupta

        Managing Director
        PS

        Prithipal Singh Kochhar

        Non Executive Director
        Show More
      • Walker Chandiok & Co. LLP
        H L Bansal & Co.

      Industry

      Pharma - Indian

      Key Indices Listed on

      -

      Address

      Innov8 3rd Floor,Plot No. 211, Okhla Phase � III,New Delhi, Delhi - 110020

      Contact

      [email protected]

      http://www.jagsonpal.com

      More Details

      FAQs about Jagsonpal Pharm share

      • 1. What's Jagsonpal Pharm share price today and what are Jagsonpal Pharm share returns ?
        Jagsonpal Pharm share price is Rs 220.44 as on 16 Oct, 2025, 03:55 PM IST. Jagsonpal Pharm share price is down by 1.10% based on previous share price of Rs 211.93. Jagsonpal Pharm share price trend:
        • Last 12 Months: Jagsonpal Pharm share price moved up 22.63%
        • Last 3 Years: Jagsonpal Pharm Share price moved up by 62.47%
      • 2. What is the market cap of Jagsonpal Pharm?
        Jagsonpal Pharm share has a market capitalization of Rs 1,466.51 Cr. Within Pharmaceuticals sector, it's market cap rank is 76.
      • 3. What are the returns for Jagsonpal Pharm share?
        Return Performance of Jagsonpal Pharm Shares:
        • 1 Week: Jagsonpal Pharm share price moved up by 3.02%
        • 6 Month: Jagsonpal Pharm share price moved up by 0.27%
      • 4. What is Jagsonpal Pharm's 52 week high / low?
        52 Week high of Jagsonpal Pharm share is Rs 328.04 while 52 week low is Rs 175.18
      • 5. What is the PE & PB ratio of Jagsonpal Pharm?
        The PE ratio of Jagsonpal Pharm stands at 24.38, while the PB ratio is 6.17.

      Trending in Markets

      Top Gainers As on 03:59 PM | 16 Oct 2025

      BLS Int. Services324.50
      45.95 (16.50%)
      Craftsman Automation6,800.50
      376.50 (5.87%)
      Oberoi Realty1,687.10
      85.70 (5.36%)
      Apar Industries8,784.50
      429.00 (5.14%)
      Ola Electric Mobilit55.38
      2.64 (4.99%)

      Top Losers As on 03:59 PM | 16 Oct 2025

      KEI Industries4,172.60
      -248.00 (-5.62%)
      Anant Raj633.35
      -29.20 (-4.41%)
      Netweb Technologies3,760.20
      -172.21 (-4.38%)
      Tata Investment906.00
      -35.00 (-3.72%)
      Max Financial1,552.40
      -56.70 (-3.53%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.

      Business News›Markets›Stocks›Stock Price Quotes›Jagsonpal Pharm Share Price
      The Economic Times
      BrowseCompanies: